Prostate Cancer Symptoms: Early Warning Signs, Risk Factors, Diagnosis and Treatment

Many men first learn about prostate cancer not from a symptom but from a number: a PSA result on a routine blood test that’s higher than expected. That’s because early prostate cancer is usually quiet. There’s often no pain, no lump and nothing that feels wrong.

That doesn’t make it rare. The American Cancer Society estimates about 333,830 new cases of prostate cancer in the United States in 2026, and about 36,320 deaths. Other than skin cancer, it’s the most common cancer in American men. At the same time, the ACS stresses that most men diagnosed with prostate cancer do not die from it, because many cases grow slowly and treatment has improved.

Understanding the warning signs, your own risk and your testing options helps you make good decisions. This guide covers all of it.

What Is the Prostate?

The prostate is a walnut-sized gland below the bladder and in front of the rectum. It surrounds the urethra, the tube that carries urine out of the body, and produces fluid that nourishes and carries sperm. Prostate cancer starts when cells in the gland begin to grow abnormally. Most prostate cancers are adenocarcinomas and, in many men, develop slowly over years.

Early Warning Signs of Prostate Cancer

In the early stages, there are often no symptoms at all. When symptoms do appear, they tend to overlap with common, non-cancerous prostate problems, which is why they shouldn’t be ignored but also shouldn’t cause panic.

Urinary symptoms:

A weak or interrupted urine stream
Trouble starting urination or straining to empty the bladder
Frequent urination, especially at night
A sudden, urgent need to urinate
Feeling the bladder hasn’t fully emptied
Pain or burning when urinating (more commonly an infection, but worth checking)

Other possible signs:

Blood in the urine or semen
Painful ejaculation
New erectile dysfunction
Discomfort or pressure in the pelvic area

Signs of more advanced disease:

Persistent pain in the lower back, hips, pelvis or upper thighs
Bone pain that doesn’t go away
Unexplained weight loss and fatigue
Leg weakness or numbness
Loss of bladder or bowel control, which needs urgent attention

Symptoms Aren’t Always Cancer

Benign prostatic hyperplasia (BPH), an age-related enlargement of the prostate, and prostatitis (inflammation or infection) cause many of the same urinary symptoms and are far more common than cancer. Still, only a doctor can tell the difference, so new or worsening urinary problems deserve an evaluation.

Who Is at Higher Risk?

Age. Risk climbs significantly after 50, and most diagnoses occur in men over 65.

Race and ethnicity. Black men face higher rates of prostate cancer and roughly twice the mortality of White men, according to American Cancer Society reporting. Because of this, many guidelines recommend that Black men talk to their doctor about screening earlier.

Family history. Having a father or brother with prostate cancer roughly doubles your risk, and more so if the relative was diagnosed young or several relatives were affected. A family history of breast, ovarian or pancreatic cancer can also be relevant.

Inherited gene changes. Mutations in genes such as BRCA1, BRCA2 and others linked to Lynch syndrome raise risk and may influence treatment choices.

Other factors under study: Obesity may be linked to a higher chance of more aggressive disease. Diet, smoking, certain chemical exposures and chronic inflammation have been studied, but the evidence is less clear than for the factors above.

How Is Prostate Cancer Screened For and Diagnosed?

Screening: The PSA Test and Digital Rectal Exam

PSA (prostate-specific antigen) blood test. PSA is a protein made by the prostate. Higher levels can signal cancer, but also BPH, prostatitis, recent ejaculation, cycling or an infection. That’s why PSA isn’t a simple “cancer yes or no” test.

Digital rectal exam (DRE). A doctor feels the prostate through the rectal wall for hard areas, lumps or irregularities. It’s quick and usually used alongside PSA.

Screening is a personal decision. The U.S. Preventive Services Task Force recommends that men ages 55 to 69 make an individual choice about PSA screening after discussing the potential benefits and harms with their clinician. The benefit is catching potentially dangerous cancer earlier. The harm is overdiagnosis, which means finding slow-growing cancers that might never have caused problems, and then potentially treating them with side effects. Men at higher risk, such as Black men or those with a strong family history, are often advised to start the conversation earlier, commonly around age 40 to 45.

Next Steps After an Abnormal Result

Repeat PSA and follow-up tests, since levels can fluctuate
Biomarker tests, such as PHI, 4Kscore or urine tests, that help estimate the likelihood of significant cancer
Prostate MRI, which has become a major tool. It can show suspicious areas and help decide whether a biopsy is needed and where to target it
Prostate biopsy, in which small tissue samples are taken from the prostate, often guided by MRI and ultrasound. A pathologist examines them under a microscope

Grading and Staging

If cancer is found, two key measures guide treatment:

Gleason score and Grade Group (1 to 5). This describes how abnormal the cancer cells look. Grade Group 1 is low-risk, while Grade Group 4 or 5 is high-grade and more aggressive.
Stage. This describes how far the cancer has spread: confined to the prostate (localized), extending beyond it (locally advanced), or spread to lymph nodes or bones (metastatic).

Additional imaging, such as PSMA PET scans, bone scans or CT, may be used for higher-risk disease to see whether cancer has spread. Doctors combine PSA level, Grade Group, stage and your overall health into a risk category: low, intermediate or high.

Prostate Cancer Treatment Options

Treatment depends on risk category, age, general health, your preferences and what side effects you’re willing to accept. It’s a decision to take your time with, and a second opinion is common and reasonable.

Active Surveillance

For low-risk cancer, many men can safely delay treatment and be closely monitored with regular PSA tests, exams, MRI and sometimes repeat biopsies. Treatment starts only if the cancer shows signs of progressing. This approach lets many men avoid or postpone side effects without compromising outcomes.

Watchful Waiting

A less intensive approach, often for older men or those with other serious health conditions, where the focus is on managing symptoms if and when they arise rather than aiming for cure.

Surgery (Radical Prostatectomy)

The prostate is removed, often with robotic-assisted techniques. It’s generally used for localized cancer in men healthy enough for surgery. Possible side effects include urinary incontinence and erectile dysfunction, which often improve over time but can be long-lasting. Nerve-sparing techniques may help preserve function in some cases.

Radiation Therapy

External beam radiation, including intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), which delivers high doses in fewer sessions
Brachytherapy, where radioactive seeds are placed in the prostate
Radiation is sometimes combined with short-term or long-term hormone therapy, particularly in intermediate- and high-risk disease. Side effects can include urinary and bowel symptoms and erectile dysfunction.

Hormone Therapy (Androgen Deprivation Therapy)

Prostate cancer cells often rely on testosterone to grow. Hormone therapy lowers testosterone or blocks its effect. It’s used with radiation for some localized cancers and as a main treatment for advanced disease. Side effects can include hot flashes, fatigue, loss of libido, weight gain, bone thinning and changes in mood, so doctors often recommend bone health monitoring and exercise.

Advanced Therapies for Metastatic Disease

For cancer that has spread or no longer responds to standard hormone therapy, options may include newer-generation hormone-blocking drugs, chemotherapy, radioligand therapy targeting PSMA, PARP inhibitors for certain gene mutations, immunotherapy for selected cases, and bone-strengthening treatments. Genetic and tumor testing can help match treatment to the cancer’s biology.

Focal Therapy and Other Approaches

Treatments such as high-intensity focused ultrasound (HIFU) or cryotherapy target only the cancerous part of the prostate in selected cases. They’re less established than surgery or radiation and are not appropriate for everyone, so it’s worth discussing availability and evidence with a specialist.

Life After a Prostate Cancer Diagnosis

Treatment is only one part of care. Many men benefit from:

Pelvic floor exercises, which can help with urinary control after surgery or radiation
Sexual health support, including medications, devices and counseling for erectile function and intimacy
Regular exercise, which improves energy, mood and treatment tolerance, and may support long-term outcomes
A heart-healthy diet and weight management, since cardiovascular disease is a leading health concern for men with prostate cancer
Emotional support, such as counseling or peer groups, because a cancer diagnosis affects mental health and relationships
Follow-up PSA monitoring, as recommended by your doctor

Can Prostate Cancer Be Prevented?

There’s no guaranteed way to prevent it. But general healthy habits are recommended, as they support overall health and may reduce risk of aggressive disease: staying physically active, keeping a healthy weight, eating plenty of vegetables, fruits and whole foods, not smoking and talking with your doctor about screening that fits your risk. Supplements marketed for prostate health haven’t been shown to prevent cancer, and some high-dose supplements may carry risks, so check with your doctor first.

When to See a Doctor

Make an appointment if you notice new urinary changes, blood in your urine or semen, persistent pelvic or back pain, or new erectile problems. Also schedule a conversation about screening if you’re in your 50s (or earlier if you have higher risk factors).

Seek urgent care for sudden inability to urinate, loss of bladder or bowel control, or new leg weakness with back pain, since these can signal an emergency.

Key Takeaways

Prostate cancer is common, often slow-growing and frequently silent in its early stages. Because symptoms overlap with benign conditions and early cancer may have none, informed screening conversations matter. Modern tools, including MRI, genetic testing and active surveillance, help doctors match treatment to the actual risk, sparing many men from unnecessary treatment while making sure aggressive cancers are caught. If you’re unsure where you fit, start by asking your doctor about your personal risk and whether PSA testing makes sense for you.

Disclaimer: This article is for general information only and isn’t a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider about your health and screening decisions.

Sources to link when publishing: American Cancer Society (Key Statistics and prostate cancer guides); National Cancer Institute (NCI) prostate cancer information; U.S. Preventive Services Task Force screening recommendation; American Urological Association patient resources.